Placebo for Bepirovirsen Solution for Injection 150 mg/mL
219288
Phase 3 small_molecule active
Quick answer
Placebo for Bepirovirsen Solution for Injection 150 mg/mL for Hepatitis B, Chronic is a Phase 3 program (small_molecule) at GlaxoSmithKline Biologicals S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline Biologicals S.A.
- Indication
- Hepatitis B, Chronic
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active